Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia. - Wikidata - awgldk - TriplyDB

Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia.

Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia.

http://www.wikidata.org/entity/Q31962510

about

Neuroprotection for ischemic stroke: past, present and future Cerebral collateral circulation in experimental ischemic stroke Biomarkers for disease progression and AAV therapeutic efficacy in feline Sandhoff disease The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2.High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial.Physiologically based model of acute ischemic stroke.ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2 Albumin reduces blood-brain barrier permeability but does not alter infarct size in a rat model of neonatal stroke.Albumin therapy improves local vascular dynamics in a rat model of primary microvascular thrombosis: a two-photon laser-scanning microscopy study Albumin therapy augments the effect of thrombolysis on local vascular dynamics in a rat model of arteriolar thrombosis: a two-photon laser-scanning microscopy study.Role of residual flow on the neuroprotective efficacy of human albumin in the rat with transient cerebral ischemia.Transient cerebral ischemia induces albumin expression in microglia only in the CA1 region of the gerbil hippocampus Prognostic significance of ischemia-modified albumin in acute ischemic stroke patients: A preliminary study.Polynitroxyl albumin and albumin therapy after pediatric asphyxial cardiac arrest: effects on cerebral blood flow and neurologic outcome.Anesthetic management of patients with intracranial aneurysms.Albumin therapy enhances collateral perfusion after laser-induced middle cerebral artery branch occlusion: a laser speckle contrast flow study Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials Acute treatment with docosahexaenoic acid complexed to albumin reduces injury after a permanent focal cerebral ischemia in rats.The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis Impaired leptomeningeal collateral flow contributes to the poor outcome following experimental stroke in the Type 2 diabetic mice.Investigational therapies for ischemic stroke: neuroprotection and neurorecovery.Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial.The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes.Docosahexaenoic acid complexed to human albumin in experimental stroke: neuroprotective efficacy with a wide therapeutic window Low admission serum albumin as prognostic determinant of 30-day case fatality and adverse functional outcome following acute ischemic stroke.Serum Albumin and High-Sensitivity C-reactive Protein are Independent Risk Factors of Chronic Kidney Disease in Middle-Aged Japanese Individuals: the Circulatory Risk in Communities Study.Serum albumin levels are associated with cardioembolic and cryptogenic ischemic strokes: Northern Manhattan Study.Albumin therapy in acute stroke patients.Developing drug strategies for the neuroprotective treatment of acute ischemic stroke.Intraventricular albumin: an optional agent in experimental post-traumatic brain edema.Repeated Oral Administration of Human Serum Albumin Protects from the Cerebral Ischemia in Rat Brain Following MCAO TGFβ signaling is associated with changes in inflammatory gene expression and perineuronal net degradation around inhibitory neurons following various neurological insults.Docosahexaenoic acid complexed to albumin provides neuroprotection after experimental stroke in aged rats.Neuroprotective effect of DAHK peptide in an occlusive model of permanent focal ischemia in rats.Increased S-nitrosothiols and S-nitrosoalbumin in cerebrospinal fluid after severe traumatic brain injury in infants and children: indirect association with intracranial pressure.Albumin level and stroke. Potential association between lower albumin level and cardioembolic aetiology.Mechanisms of lysophosphatidylcholine-induced demyelination: A primary lipid disrupting myelinopathy.The pre-treatment effect on brain injury during restoration of normal perfusion pressure with hemodilution in a new rat model of chronic cerebral hypoperfusion.fMRI of delayed albumin treatment during stroke recovery in rats: implication for fast neuronal habituation in recovering brains.Evaluation of routinely performed hematological and biochemical parameters for the prognosis of acute ischemic stroke patients.

P2860

Q24645185-59076216-6840-4728-948E-42AA07ADD3AE Q26765095-5CFA4EC8-2AF5-48C2-BA0E-3E959AD17646 Q30394711-F1B51952-3D93-4F43-8CC4-0F1F9DA97065 Q30429188-8B6A32BF-23D2-4888-8D81-4C400DEDAA39 Q30572344-5999EC9A-6367-45A3-AD20-B7942F6B281A Q30712546-1F913D61-7B7B-49B0-A740-0D74E694806E Q31117815-D5DE9BA9-412F-4812-82A0-2DB1E0635AE5 Q31118233-56F4B8E2-300F-4276-9019-3447B78C8A8E Q33306793-DDC02260-4556-45FC-BEE6-B86BE309FAAF Q33322705-6AC47096-5E84-433D-A72A-5886164D884E Q33464775-B3A00DFC-B3C4-49C6-B1EC-ECD122854FDA Q33828068-3FC9790B-B3F2-4370-A245-22A1E87D5B88 Q33979457-0698829B-7F51-41F8-98FC-C68BC676D79D Q34086176-B9003512-849F-4D71-9BDC-01DB7AA3470A Q34228630-373F0595-1056-42B3-BCA3-4FA9D5C40465 Q34332600-19EBE14F-29BA-4B26-AA29-9F40FB120380 Q34972793-BC0FA9F0-570A-4D3B-866C-26EE97AC743B Q35032398-11DACA6D-73AC-4BAB-AA83-2B042756874C Q35055490-7BB65313-B635-4586-A9BA-AFCC483D2257 Q35142897-845D470F-1840-4B91-908C-AE2DC5FF7F8B Q35648103-DEF3CCC7-C01E-464E-988B-8803A13C026B Q35760931-A41EC132-FAA9-47D5-8027-AB88C8D4B45C Q35784963-7520D0F9-3BEA-4260-8460-B4A340875950 Q36517694-331F6E26-A131-4251-9202-B0F5D4A44AE3 Q36743297-4F0ADAD8-2172-4BB8-8B60-9073BE3E8DDC Q37387222-DB40977F-5277-4EB6-9E95-577849F25E20 Q37666082-BF22D3C5-D519-49FC-B81B-3873DDA9DA7E Q38506339-504E6FCD-54E0-4665-BEC2-4C54106EFACF Q40429078-C1DED773-DB23-42B7-8342-7119C13B5A2A Q40430761-8E49A8AC-D725-4D20-94FB-B1E96CDC9E36 Q40998742-71B58394-167E-4521-B407-7E8A5E4BEDA4 Q41332318-47668518-D553-45EF-AF09-1E492FA60386 Q41845026-C4585132-FD3D-4234-A90C-C995DA11EF98 Q43272189-6E03C95A-B3F2-42FB-9F1B-1DEB6D413496 Q44261067-CFEBBE16-AD17-419A-A2AB-9398ED9793CF Q44749615-775776CF-3AE1-4111-A6E3-D53D6D54879F Q48001723-C4BD50AE-4637-4A9C-802C-B46BCA2BEECE Q48153289-6300C7ED-8D7D-479C-A67A-99B92DF3AA35 Q48516504-39D9858F-DB06-4752-A81F-80AA3DCA7973 Q48935810-2D83B034-6327-42B0-BC07-63D6503E2BDC

P2860

Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia.

http://www.wikidata.org/entity/Q31962510

description

1998 nî lūn-bûn

@nan

1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Diffusion-weighted magnetic re ...... py in focal cerebral ischemia.

@ast

Diffusion-weighted magnetic re ...... py in focal cerebral ischemia.

@en

type

label

Diffusion-weighted magnetic re ...... py in focal cerebral ischemia.

@ast

Diffusion-weighted magnetic re ...... py in focal cerebral ischemia.

@en

prefLabel

Diffusion-weighted magnetic re ...... py in focal cerebral ischemia.

@ast

Diffusion-weighted magnetic re ...... py in focal cerebral ischemia.

@en

P1433

Q31962510-44D365F5-4D5B-4964-B1E5-BD88FFA34C7F

P1476

Q31962510-76B7D363-69D0-41B0-B04B-96C499D77CEF

P2093

Q31962510-60309B27-3536-4E82-BA01-C9BB7CD062B3

Q31962510-8017B860-7FD6-4247-B529-F5A76AE520FA

Q31962510-8D262BF7-4DD2-4B24-9695-92D1AAD9BCDD

Q31962510-993B07D8-476E-444B-9A4B-7EA9CAAF0A79

Q31962510-9C9E378A-3364-418C-9A83-A76E41029DB4

Q31962510-D78D933B-F26A-4083-A7E9-451A1225EAF4

Q31962510-DE913CC4-A01A-420E-B313-CF84364318FA

Q31962510-EE0AC377-6545-4ADC-8B90-94F9EF1E7332

P304

Q31962510-030E779B-699A-4742-AD9E-C8713E047BD8

P31

Q31962510-C51E29A2-C1FD-4444-B5AF-89C911E66297

P356

Q31962510-22599E7D-1CEF-433A-8862-C4F10C901FA6

P407

Q31962510-C5461D80-1285-4D50-9BD1-9B0BEC621108

P433

Q31962510-A9A2E0E8-6C5C-4133-86B2-35949C1850DE

P478

Q31962510-0907A79D-AE0B-4D6C-8E75-5CE185DCBB45

P577

Q31962510-E5B8D28D-D26D-49FD-BF94-6D5702343533

P698

Q31962510-E43311BD-3C75-44B4-9A3A-C1B354ED108C

P921

Q31962510-F3BCCCF8-CF60-4C73-B819-EF5A99046209

P356

01.STR.29.12.2587

P1433

P1476

Diffusion-weighted magnetic re ...... py in focal cerebral ischemia.

@en

P2093

B Lin

http://www.w3.org/2001/XMLSchema#string

L Belayev

http://www.w3.org/2001/XMLSchema#string

M D Ginsberg

http://www.w3.org/2001/XMLSchema#string

P M Pattany

http://www.w3.org/2001/XMLSchema#string

P W Huh

http://www.w3.org/2001/XMLSchema#string

R Busto

http://www.w3.org/2001/XMLSchema#string

R G Weaver

http://www.w3.org/2001/XMLSchema#string

W Zhao

http://www.w3.org/2001/XMLSchema#string

P304

2587-2599

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.STR.29.12.2587

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

1998-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9836772

http://www.w3.org/2001/XMLSchema#string

P921

cerebral infarction